BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 8381885)

  • 21. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
    Yamada S; Asakura H
    Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in the activation markers of blood coagulation and fibrinolysis in the neonatal period].
    Ries M; Klinge J; Rauch R; Zenker M; Aydin I; Harms D
    Klin Padiatr; 1996; 208(6):350-4. PubMed ID: 9064377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers.
    Wada H; Gabazza E; Nakasaki T; Shimura M; Hiyoyama K; Deguchi K; Nishikawa M; Sakuragawa N; Shiku H
    Semin Thromb Hemost; 2000; 26(1):17-21. PubMed ID: 10805276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention and early diagnosis of disseminated intravascular coagulation].
    Matsuda T
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1375-82. PubMed ID: 8245630
    [No Abstract]   [Full Text] [Related]  

  • 25. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemostatic molecular markers before the onset of disseminated intravascular coagulation.
    Wada H; Sakuragawa N; Mori Y; Takagi M; Nakasaki T; Shimura M; Hiyoyama K; Nisikawa M; Gabazza EC; Deguchi K; Kazama M; Shiku H
    Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
    Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome.
    Suharti C; van Gorp EC; Setiati TE; Dolmans WM; Djokomoeljanto RJ; Hack CE; ten CH; van der Meer JW
    Thromb Haemost; 2002 Jan; 87(1):42-6. PubMed ID: 11858187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis of predictive state of disseminated intravascular coagulation].
    Yamamoto K; Saito H
    Nihon Rinsho; 1993 Jan; 51(1):74-8. PubMed ID: 8433531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adequate parameters for the diagnosis of disseminated intravascular coagulation (DIC) in patients with liver diseases].
    Iwabuchi S; Takatori M; Okabe K
    Nihon Rinsho; 1993 Jan; 51(1):67-73. PubMed ID: 8381886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K
    Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
    Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
    Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
    Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
    Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between clotting and collagen metabolism markers in rheumatoid arthritis.
    Gabazza EC; Osamu T; Yamakami T; Ibata H; Sato T; Sato Y; Shima T
    Thromb Haemost; 1994 Feb; 71(2):199-202. PubMed ID: 7514817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections.
    Asakura H; Wada H; Okamoto K; Iba T; Uchiyama T; Eguchi Y; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S
    Thromb Haemost; 2006 Feb; 95(2):282-7. PubMed ID: 16493490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of thrombin-antithrombin III complex and plasmin-alpha 2 plasmin inhibitor complex in chronic liver diseases].
    Ohmoto K; Yamamoto S; Ideguchi S; Yamamoto R; Takatori K; Ohumi T; Hino K; Hirano Y
    Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1837-45. PubMed ID: 2147451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
    Wada H; Sakuragawa N; Shiku H
    Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.